查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589727

事后紧急避孕药市场：按类型、类别、年龄层、分布划分 - 全球预测 2025-2030

Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年事后紧急避孕药市场价值为10.2亿美元，预计2024年将达到10.8亿美元，复合年增长率为6.49%，到2030年将达到15.8亿美元。

事后紧急避孕药(ECP) 是更广泛的避孕药市场中的重要部分，主要用于性交后预防意外怀孕。 ECP 包括荷尔蒙製剂，包括levonorgestrel和醋酸乌利司他，在性交后 72 至 120 小时内最有效。当主要避孕方法失败时，ECP 可以充当安全网，在降低堕胎率方面发挥作用，这凸显了 ECP 的必要性。 ECP 主要用于避孕失败、无保护性行为和性侵犯的情况。最终用途范围涵盖不同的人口统计数据，主要针对已开发和发展中地区的育龄妇女。市场成长主要是由于认知度和可用性的提高，尤其是几个地区的店面销售。对妇女生殖健康和自主权的日益关注进一步推动了需求。然而，文化和宗教的反对、有关安全性和有效性的错误讯息以及某些地区的监管障碍对成长构成了挑战。潜在的商机在于扩大宣传宣传活动和利用数位平台进行教育。与医疗保健提供者合作以确保明智的决策和广泛的准入也可能提高市场渗透率。创新可以集中在改进配方以延长保质期，并探索生物分解性的包装以吸引具有环保意识的消费者。市场本质上对社会状况和法律体系的趋势很敏感，凸显了适应性的必要性。儘管存在障碍，但越来越多的人接受紧急避孕作为全面计划生育的一部分，这代表着一条充满希望​​的业务成长之路。强调基于证据的教育和游说支持性政策有助于缓解挑战。该市场的动态性质强调了与消费者持续接触和策略伙伴关係关係的重要性，以创造一个支持 ECP 接受和使用的环境。

主要市场统计
基准年[2023] 10.2亿美元
预测年份 [2024] 10.8亿美元
预测年份 [2030] 15.8亿美元
复合年增长率（%） 6.49%

市场动态：快速发展的事后紧急避孕药市场的关键市场洞察

供需的动态交互作用正在改变事后紧急避孕药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 美国因意外怀孕而收养的人数增加。
    • 政府努力促进避孕药的使用
  • 市场限制因素
    • 效能问题、事后紧急避孕药召回问题
  • 市场机会
    • 製造商加强研发和联合宣传宣传活动
    • 透过线上管道轻鬆获取
  • 市场挑战
    • 服用事后紧急避孕药可能产生的副作用

波特的五力：驾驭事后紧急避孕药市场的策略工具

波特的五力框架是了解事后紧急避孕药市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解事后紧急避孕药市场的外部影响

外部宏观环境因素对事后紧急避孕药市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解事后紧急避孕药市场竞争状况

对事后紧急避孕药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵事后紧急避孕药市场供应商的绩效评估

FPNV 定位矩阵是评估事后紧急避孕药市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划事后紧急避孕药市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，事后紧急避孕药市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 美国因意外怀孕而收养的收养呈上升趋势
      • 政府努力促进避孕药具的使用
    • 抑制因素
      • 事后紧急避孕药功效和召回率问题
    • 机会
      • 加强製造商的研发和联合宣传活动
      • 透过线上管道轻鬆获得
    • 任务
      • 服用事后紧急避孕药可能产生的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章事后紧急避孕药市场：依类型

  • 抗黄体素
  • 复方药物
  • 黄体酮锭剂

第七章事后紧急避孕药市场：依类别

  • 品牌
  • 非专利的

第八章事后紧急避孕药市场：依年龄段

  • 15-24
  • 25-34
  • 35-44
  • 45岁以上

第九章事后紧急避孕药市场经销商

  • 离线
  • 在线的

第十章美洲事后紧急避孕药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太事后紧急避孕药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲事后紧急避孕药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 美国政府签署行政命令扩大避孕措施
    • Gedeon Richter 从 Consilient Health 收购口服避孕药领域
    • 医疗保健Start-Ups获得破产避孕药具提供者的病患记录
    • 事后避孕药品牌可加快进入零售商的速度并使每包供应量增加一倍
    • Curae Pharma360 推出非处方事后紧急避孕药，以促进公平、可靠地获得药物，并与 Direct Relief 合作，为服务不足的女性提供医疗保健。
    • Aurobindo Pharma 避孕药已获得美国FDA核准
    • Perrigo 旗下 HRA Pharma 向 FDA 提交第一个非处方避孕药申请
    • Lupin 在美国推出非专利避孕药 Melze 胶囊
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Curae Pharma360 Inc.
  • Foundation Consumer Healthcare, LLC
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer, Inc.
  • Piramal Enterprises Ltd.
  • Rapha Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Viatris Inc.
  • Wockhardt USA LLC
  • Xiromed, LLC
Product Code: MRR-43798151BF31

The Emergency Contraceptive Pills Market was valued at USD 1.02 billion in 2023, expected to reach USD 1.08 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.58 billion by 2030.

Emergency contraceptive pills (ECPs) represent a critical segment of the broader contraceptive market, primarily used post-coitus to prevent unintended pregnancies. The scope of ECPs encompasses hormonal formulations, including levonorgestrel and ulipristal acetate, which are most effective within 72 to 120 hours post-intercourse. The necessity for ECPs is underscored by their role in reducing abortion rates by serving as a safety net when primary contraceptive methods fail. They are predominantly applied in cases of contraceptive failure, unprotected intercourse, or sexual assault. The end-use scope extends across various demographics, predominantly targeting women of reproductive age in both developed and developing regions. Market growth is primarily driven by increased awareness and accessibility, particularly through over-the-counter availability in several regions. Rising focus on women's reproductive health and autonomy further fuels demand. However, growth is challenged by cultural and religious opposition, misinformation regarding safety and efficacy, and regulatory barriers in certain geographies. Potential opportunities lie in expanding awareness campaigns and leveraging digital platforms for education. Collaborations with healthcare providers to ensure informed decisions and broader access could also enhance market penetration. Innovations can focus on enhanced formulations offering extended efficacy windows, and research into biodegradable packaging to appeal to eco-conscious consumers. The market is inherently sensitive to social and legislative developments, highlighting the need for adaptability. Despite the barriers, the increasing acceptance of emergency contraception as part of comprehensive family planning presents a promising avenue for business growth. Emphasizing evidence-based education and lobbying for supportive policies could mitigate challenges. The market's dynamic nature underscores the importance of continuous consumer engagement and strategic partnerships to foster a supportive environment for ECP acceptance and use.

KEY MARKET STATISTICS
Base Year [2023] USD 1.02 billion
Estimated Year [2024] USD 1.08 billion
Forecast Year [2030] USD 1.58 billion
CAGR (%) 6.49%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Emergency Contraceptive Pills Market

The Emergency Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising adoption owing to unintended pregnancies in the U.S.
    • Government initiatives to promote use of contraceptive pills
  • Market Restraints
    • Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
  • Market Opportunities
    • Increasing R&D and collaborative awareness campaigns by manufacturers
    • Easy availability through online channel
  • Market Challenges
    • Probable side effects associated with consuming emergency contraceptive pills

Porter's Five Forces: A Strategic Tool for Navigating the Emergency Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Emergency Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Emergency Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Emergency Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Emergency Contraceptive Pills Market

A detailed market share analysis in the Emergency Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Emergency Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Emergency Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Emergency Contraceptive Pills Market

A strategic analysis of the Emergency Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antiprogestin, Combination Pills, and Progesterone Pills.
  • Based on Category, market is studied across Branded and Generic.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Distribution, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising adoption owing to unintended pregnancies in the U.S.
      • 5.1.1.2. Government initiatives to promote use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding the effectiveness and incidences of recall of emergency contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D and collaborative awareness campaigns by manufacturers
      • 5.1.3.2. Easy availability through online channel
    • 5.1.4. Challenges
      • 5.1.4.1. Probable side effects associated with consuming emergency contraceptive pills
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Emergency Contraceptive Pills Market, by Type

  • 6.1. Introduction
  • 6.2. Antiprogestin
  • 6.3. Combination Pills
  • 6.4. Progesterone Pills

7. Emergency Contraceptive Pills Market, by Category

  • 7.1. Introduction
  • 7.2. Branded
  • 7.3. Generic

8. Emergency Contraceptive Pills Market, by Age Group

  • 8.1. Introduction
  • 8.2. 15-24
  • 8.3. 25-34
  • 8.4. 35-44
  • 8.5. 45 and Above

9. Emergency Contraceptive Pills Market, by Distribution

  • 9.1. Introduction
  • 9.2. Offline
  • 9.3. Online

10. Americas Emergency Contraceptive Pills Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Emergency Contraceptive Pills Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Emergency Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Government of the United States Signed an Executive Order Expanding Access to Birth Control
    • 13.3.2. Gedeon Richter Acquires Oral Contraceptive Range from Consilient Health
    • 13.3.3. Health-Care Startup Up Acquires Patient Records of Bankrupt Birth Control Provider
    • 13.3.4. Morning After Pill Brand Speeds Up Retail Access, Doubles Supply Per Pack
    • 13.3.5. Curae Pharma360 Launches OTC Emergency Contraception to Advance Equitable, Reliable Access to Medicines; Partners with Direct Relief to Reach Underserved Women
    • 13.3.6. Aurobindo Pharma Receives USFDA Nod for Contraceptives
    • 13.3.7. Perrigo's HRA Pharma Submits Application to FDA for First-Ever OTC Birth Control Pill
    • 13.3.8. Lupin Launches Generic Contraceptive Drug Merzee Capsules in U.S.
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Afaxys Pharma, LLC
  • 3. Amneal Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Aurobindo Pharma Limited
  • 6. Bayer AG
  • 7. Bionpharma Inc.
  • 8. Cipla Limited
  • 9. Combe Incorporated
  • 10. Curae Pharma360 Inc.
  • 11. Foundation Consumer Healthcare, LLC
  • 12. Gedeon Richter PLC
  • 13. Glenmark Pharmaceuticals Limited
  • 14. Julie Product Inc.
  • 15. Lupin Limited
  • 16. Mankind Pharma Ltd.
  • 17. Merck & Co., Inc.
  • 18. Northstar Rx LLC
  • 19. Perrigo Company plc
  • 20. Pfizer, Inc.
  • 21. Piramal Enterprises Ltd.
  • 22. Rapha Pharmaceuticals, Inc.
  • 23. Sun Pharmaceutical Industries Limited
  • 24. Syzygy Healthcare Solutions, LLC
  • 25. Viatris Inc.
  • 26. Wockhardt USA LLC
  • 27. Xiromed, LLC

LIST OF FIGURES

  • FIGURE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EMERGENCY CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ANTIPROGESTIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023